WEIGHT LOSS MEDICATIONS REDUCE COLON CANCER RISK Newly completed research published in the scientific journal JAMA Oncology (Journal of the […]

December 19, 2023

ZEPBOUND : THE NEW WEIGHT LOSS MEDICATION The FDA has just published a news release regarding its approval of Zepbound […]

November 14, 2023

A comparison of two drugs used to treat type 2 diabetes found that tirzepatide (Mounjaro) was superior to semaglutide (Ozempic) at blood […]

November 10, 2023

Polycystic Ovarian Syndrome (PCOS) is a condition of hormonal imbalance that is characterized by menstrual cycle irregularity, weight gain, fertility problems, […]

October 31, 2023

Tirzepatide Tirzepatide (Mounjaro) ia a once weekly GIP (glocose-dependent insulinoptropic polypeptide0 receptor and GLP-1 (glucagon-like peptide-1) receptor agonist. Tirzepatide activates the body’s receptors […]

October 19, 2023
Scroll to Top
Call Now